Osborne Clarke advised NeRRe Therapeutics on the deal.The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now